At the end of the latency period, the return message is received and the scheduler allocates a channel as defined in the allocation table. The scheduled channel is used to transmit the message to or from the corresponding subscriber.FARLEY, KEVIN L...
Novel ester derivatives of ascorbic acid and 2-keto-acid saccharides are provided wherein the ester is introduced by ester bond formation between at least one hydroxy-functionality on the ascorbic acid or 2-keto-acid saccharide and a carboxy-functional organosiloxane, or between a 2-keto-gulonic...
The present invention provides a kind of stable peptide conjugation, ascorbic acid derivates, and a kind of to prepare identical and cosmetic composition include it as active constituent. Stable ascorbic acid derivates have both the effect of the skin brightening of the invention of peptide ...
DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATESThe invention provides dry powder pharmaceutical formulations comprising an ascorbic acid derivative that demonstrate good inhalation performance and dry powder inhalers containing them.Jan Trofast...
The other compounds showed significant to moderate activities in both the methods in comparison with ascorbic acid and butylated hydroxytoluene as standards. Compounds exhibited good anticancer activity, using Michigan Cancer Foundation-7 (MCF-7) cell line, compared with those of other synthesized ...
Compounds of formula (I) may be prepared by reacting a furan, e.g. 2-methyl-2, 5-dimethoxy-2,5-dihydrofuran, with a butyrolactone, e.g. L-ascorbic acid, and are useful for modulating the immune system of humans and other animals.doi:CA1323374 CALBERT SZENT GYORGYIGABOR B. FODOR...
The present invention enables questioners to ask questions easily without limitation of time and place, and enables answerers to register as answerers without complicated processes and much time consumption. A mediation center apparatus 1 receives registration as answerers from mobile phones 9 owned by ...
DRY POWER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATESThe invention provides dry powder pharmaceutical formulations comprising an ascorbic acid derivative that demonstrate good inhalation performance and dry powder inhalers containing them.TROFAST JAN
DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATESThe invention provides dry powder pharmaceutical formulations comprising an ascorbic acid derivative that demonstrate good inhalation performance and dry powder inhalers containing them.
DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATESThe invention provides dry powder pharmaceutical formulations comprising an ascorbic acid derivative that demonstrate good inhalation performance and dry powder inhalers containing them.TROFAST JAN...